LONDON (Reuters) - A U.S. biotechnology firm said on Wednesday it had developed a new technique to produce genetically modified chickens that could be used to produce treatments for human diseases.
The technology, devised by scientists at the privately-owned California company Origen Therapeutics and researchers at the University of California, Davis, may also lead to improved poultry production and chickens resistant to avian flu.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
